Literature DB >> 22732857

Prostate cancer: new treatments for localized tumours-what matters first?

Bertrand Guillonneau1.   

Abstract

High-intensity focused ultrasound (HIFU) represents a fairly new treatment option for focal therapy of prostate cancer. However, studies evaluating its efficacy have not provided strong data to support the use of HIFU in the majority of patients. Thus, high-profile studies investigating feasibility of the modality in terms of adverse effects seem premature.

Entities:  

Mesh：

Year:  2012        PMID： 22732857     DOI： 10.1038/nrurol.2012.133

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


  6 in total

1.  Seven years of experience with high-intensity focused ultrasound for prostate cancer: advantages and limitations.

Authors:  Hyun Hwan Sung; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Han-Yong Choi; Hyun Moo Lee
Journal:  Prostate       Date:  2012-01-17       Impact factor: 4.104

2.  Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer.

Authors:  Romain Boutier; Nicolas Girouin; Alexandre Ben Cheikh; Aurélien Belot; Muriel Rabilloud; Albert Gelet; Jean-Yves Chapelon; Olivier Rouvière
Journal:  BJU Int       Date:  2011-06-28       Impact factor: 5.588

3.  Six years' experience with high-intensity focused ultrasonography for prostate cancer: oncological outcomes using the new 'Stuttgart' definition for biochemical failure.

Authors:  Thomas Ripert; Marie-Dominique Azémar; Johann Ménard; Coralie Barbe; Rabah Messaoudi; Younes Bayoud; Jean Pierrevelcin; François Duval; Frédéric Staerman
Journal:  BJU Int       Date:  2010-11-17       Impact factor: 5.588

4.  Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry.

Authors:  A Blana; C N Robertson; S C W Brown; C Chaussy; S Crouzet; A Gelet; G N Conti; R Ganzer; G Pasticier; S Thuroff; J F Ward
Journal:  Prostate Cancer Prostatic Dis       Date:  2012-09       Impact factor: 5.554

5.  Focal therapy for localized prostate cancer: a phase I/II trial.

Authors:  H U Ahmed; A Freeman; A Kirkham; M Sahu; R Scott; C Allen; J Van der Meulen; M Emberton
Journal:  J Urol       Date:  2011-02-22       Impact factor: 7.450

6.  Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study.

Authors:  Hashim U Ahmed; Richard G Hindley; Louise Dickinson; Alex Freeman; Alex P Kirkham; Mahua Sahu; Rebecca Scott; Clare Allen; Jan Van der Meulen; Mark Emberton
Journal:  Lancet Oncol       Date:  2012-04-17       Impact factor: 41.316
  6 in total
  1 in total

1.  Oncogenic Role of the Ec Peptide of the IGF-1Ec Isoform in Prostate Cancer.

Authors:  Athanasios Armakolas; Maria Kaparelou; Andreas Dimakakos; Efstathia Papageorgiou; Nikolaos Armakolas; Athanasios Antonopoulos; Constantina Petraki; Maria Lekarakou; Pavlos Lelovas; Martha Stathaki; Constantinos Psarros; Ismene Donta; Panos S Galanos; Paul Msaouel; Vassilis G Gorgoulis; Michael Koutsilieris
Journal:  Mol Med       Date:  2015-01-06       Impact factor: 6.354
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.